June 30 (Reuters) - Prima Biomed Ltd PRR.AX
* Entered into a securities purchase agreement with certain accredited investors to purchase 2.6 million of its american depositary shares
* Total gross proceeds of approximately us$5.0 million
* To purchase its american depositary shares at a purchase price of us$1.90 per ads in a registered direct offering
* Prima intends to use net proceeds from this offering to continue ongoing clinical development of imp321 Source text for Eikon: ID:nASX1n8vSh Further company coverage: PRR.AX
(bangalore.newsroom@thomsonreuters.com)